{"SPADE_UN_17832": {"Clinical Information": [], "Patent Information": [{"Patent No": "CN111344298A", "Patent Link": "http://www.lens.org/lens/patent/CN111344298A", "Patent Type": "Granted Patent", "Publication Date": "2020-6-26", "Family Info": "Notavailable", "Patent Title": "Anti-cancer agent", "Abstract": "An anticancer agent is provided comprising a tumor targeting peptide having or having been modified to present two cysteine residues with an arsenic atom between them such that the tumor targeting peptide is cyclized to produce an arsenic-containing anticancer agent. This allows selection of appropriate tumor targeting peptides for treatment of a given cancer, whereby subsequent agents provide more targeted delivery of arsenic to the tumor microenvironment."}], "Sequence Information": {"SPADE ID": "SPADE_UN_17832", "Sequence": "CPHNLTKLC", "Sequence Length": 9, "Source": "Synthetic", "Biological Activity": ["Antimicrobial", "Anticancer"], "Frequent Amino Acids": "CLH", "Absent Amino Acids": "ADEFGIMOQRSUVWY", "Basic Residues": 2, "Acidic Residues": 0, "Hydrophobic Residues": 3, "Polar Residues": 6, "Positive Residues": 2, "Negative Residues": 0, "Mass": 1028.25, "PI": 8.07, "Net Charge": 2, "Hydrophobicity": -0.03, "Similar Sequences": [{"SPADE_ID": "SPADE_N_13939", "Similarity": 1.0, "Sequence": "RHCLRSKRPPNVCPH"}, {"SPADE_ID": "SPADE_UN_25718", "Similarity": 1.0, "Sequence": "RHCLRSKRPPNVCPH"}, {"SPADE_ID": "SPADE_N_00370", "Similarity": 1.0, "Sequence": "KLCERSSGTWSGVCGNNNACKNQCIRLEGAQHGSCNYVFPAHKCICYFPC"}]}}}